Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant GD2 (Naxitamab Biosimilar) antibody

The Human Monoclonal anti-GD2 (Naxitamab Biosimilar) antibody is suitable to detect GD2 (Naxitamab Biosimilar) in samples from Human. It has been validated for ELISA, BLI, FACS, Func and SPR.
Catalog No. ABIN7676126
$346.15
Plus shipping costs $50.00
Shipping to: United States
Delivery in 10 to 12 Business Days

Quick Overview for Recombinant GD2 (Naxitamab Biosimilar) antibody (ABIN7676126)

Target

GD2 (Naxitamab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

  • 1
  • 1
Human

Host

  • 1
  • 1
Human

Clonality

  • 2
Monoclonal

Conjugate

  • 2
This GD2 (Naxitamab Biosimilar) antibody is un-conjugated

Application

ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    Purpose

    Anti-GD2 Reference Antibody (naxitamab)

    Sequence

    QVQLVESGPG VVQPGRSLRI SCAVSGFSVT NYGVHWVRQP PGKGLEWLGV IWAGGITNYN SAFMSRLTIS KDNSKNTVYL QMNSLRAEDT AMYYCASRGG HYGYALDYWG QGTLVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK,EIVMTQTPAT LSVSAGERVT ITCKASQSVS NDVTWYQQKP GQAPRLLIYS ASNRYSGVPA RFSGSGYGTE FTFTISSVQS EDFAVYFCQQ DYSSFGQGTK LEIKRTVAAP SVFIFPPSDE QLKSGTASVV CLLNNFYPRE AKVQWKVDNA LQSGNSQESV TEQDSKDSTY SLSSTLTLSK ADYEKHKVYA CEVTHQGLSS PVTKSFNRGE C

    Characteristics

    Anti-GD2 Reference Antibody (naxitamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    Purity

    >95 %

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Therapeutic Agents by Target and Mechanism: GD2 inhibitors

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    1 mg/mL

    Buffer

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    Storage

    4 °C,-80 °C

    Storage Comment

    +4°C,-80°C
  • Target

    GD2 (Naxitamab Biosimilar)

    Target Type

    Biosimilar

    Molecular Weight

    145.5 kDa
You are here:
Chat with us!